Phenotype of COVID-19-Associated Hyperinflammation Linked to Escalation of Respiratory Support, Survival
Researchers evaluated a specific phenotype of COVID-19-associated hyperinflammation and its association with escalation of patient care.
COVID19
FDA May Approve COVID-19 Vaccines Before Clinical Trials Completion
Emergency use authorization or approval for a COVID-19 vaccine before phase 3 clinical trials are complete could be considered by the US FDA.
Low Rates of Severe Disease, Death Reported in Children With COVID-19
Severe disease and death appear to be rare among children and young people hospitalized with laboratory-confirmed COVID-19.
Abbott’s 15-Minute COVID-19 Antigen Test Gets Emergency Use Authorization
The FDA issued an Emergency Use Authorization for BinaxNOW™ COVID-19 Ag Card a rapid antigen test for the detection of COVID-19.
Prevalence of SARS-CoV-2 in Asymptomatic Children Identified
Prevalence of SARS-CoV-2 in asymptomatic children linked to incidence of COVID-19 in general population.
![When communicating with patients, it is essential to provide them with key information about their drug regimen, including what the drug is, why they need it, when and how to take it, and for how long they need to take it. [6] They should also be educated about the fluctuating nature of RA, the consequences of nonadherence, and the potential adverse effects associated with their treatment so that they know what to expect and when to call for instruction, reducing the risk of them altering their regimen. [6,10] Because patients of lower socioeconomic status and ethnic minorities are at especially high risk of nonadherence, the RESPECT model of communicating, which has received recognition for improving cultural competence and overall rapport, might be especially beneficial in the RA setting. RESPECT comprises seven core elements: Respect (show), Explain (provide), Support (provide), Power (share), Empathy (show), Concerns (address), and Trust (build). [11]](https://1fxghyessyy2gaob23ygwzph-wpengine.netdna-ssl.com/wp-content/uploads/sites/18/2019/01/5doctorchartcomputerts541_1041336-544x306.jpg)
Rheumatologists Face Challenges in Identifying High-Quality COVID-19 Literature
Study authors highlighted the challenges associated with the identification of published COVID-19 literature and suggested resources for rheumatologists and their patients.
Trial Evaluating Monoclonal Antibody Combination for COVID-19 Begins
A phase 1 study of AstraZeneca’s investigational monoclonal antibody AZD7442 for COVID-19 has been initiated.
World’s First Confirmed Case of COVID-19 Reinfection Reported in Hong Kong
The world’s first confirmed case of reinfection with the new coronavirus has been reported in Hong Kong.
Systemic Autoimmune Conditions Increase Hospitalization Risk in COVID-19
Researchers described patients with autoimmune inflammatory rheumatic diseases with COVID-19 and the risk factors associated with hospitalization related to COVID-19.
Emergency Use Authorization Issued for COVID-19 Convalescent Plasma
The FDA has issued an Emergency Use Authorization (EUA) for the use of COVID-19 convalescent plasma.
-
Loading...
-
Loading...
Next post in General Rheumatology
